COVID-19 virus’s weekly COVID-19 news round-up

pharmafile | May 5, 2021 | News story | Research and Development COVID-19, COVID-19 vaccine, covid 19 news, covid-19 news, pharma, pharma news 

The past week has seen more COVID-19 vaccine and treatment news: Moderna will supply up to 500 million jabs to the COVAX worldwide vaccination programme, Celltrion’s treatment has shown promise against the South African variant of the virus, and a study has suggested that just a single dose of a vaccine may cut transmissions in half.

1. Moderna to supply up to 500 million COVID-19 vaccines to COVAX – Published 04/05/2021

Moderna have announced a supply agreement with Gavi, the Vaccine Alliance, for up to 500 million doses of their COVID-19 vaccine, including an initial 34 million doses to be delivered in the fourth quarter of 2021.

2. Celltrion’s COVID-19 treatment shows promise against South African variant – Published 30/04/21

Celltrion’s regdanvimab treatment for COVID-19 has shown itself to be effective against the South African variant of the virus, according to preliminary results from a pre-clinical trial.

3. Moderna up investments to produce 3 billion COVID vaccine doses in 2022 – Published 29/04/21

Moderna have announced it is making new funding commitments to increase supply at its owned and partnered manufacturing facilities, which it expects will increase global 2022 capacity to up to 3 billion doses of its COVID-19 vaccine.

4. COVID Symptom Study app reveals most common vaccine side effects – Published – 28/04/21

An analysis of over 600,000 people’s vaccine reports has been published in The Lancet Infectious Diseases journal, in the largest real-life study of COVID-19 vaccine side-effects in the world.

5. Single dose of COVID vaccine can cut transmissions in half – Published 28/04/21

A Public Health England (PHE) study into the Pfizer-BioNTech and Oxford-AstraZeneca vaccines has found that a single dose of either jab can cut COVID-19 transmissions by up to half.

Jack Goddard

Related Content

FDA approves first oral antiviral to treat adult patients with COVID-19

The US Food and Drug Administration (FDA) has announced that it has approved the oral …


Moderna and Pfizer COVID-19 vaccine protection declines over time

Data presented by Pfizer and Moderna ahead of the FDA’s vaccine advisory committee meeting on …

Sanofi complete acquisition of mRNA company Translate Bio

French pharma giants Sanofi continues its run of acquisitions in 2021 by completing the deal …

Latest content